Partial federal government shutdown
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
Extracorporeal membrane oxygenation therapy (ECMO)
Extracorporeal membrane oxygenation (ECMO) is a form of life support that provides cardiopulmonary assistance outside the body.
Status: Decision completed
Why is ECMO being reviewed?
Due to the expense and intensity of critical care, guidelines about how to implement life-sustaining and life-saving technologies warrant careful attention. Although consensus around when ECMO is indicated is still developing, the use of ECMO has grown in recent years and continues to rise subsequent to the H1N1 pandemic in 2009. Because the availability of ECMO is limited and requires specialized medical care, liberalizing its use in the intensive care or operating room settings has important policy implications.
Primary criteria ranking
- Safety = High
- Efficacy = High
- Cost = High
Documentation
| Type | Materials |
|---|---|
| Assessment (2016) |
Assessment timeline
- Draft key questions published: September 24, 2015
- Public comment period: September 24 to October 8, 2015
- Final key questions published: October 20, 2015
- Draft report published: December 16, 2015
- Public comment period: December 16, 2015 to January 14, 2016
- Final report published: February 12, 2016
- HTCC public meeting: March 18, 2016